• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

New technique switches key biomolecules on and off

Bioengineer by Bioengineer
December 13, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new technique that will allow scientists to determine the effects of turning on and off a set of molecules involved in almost every cellular pathway, determine their downstream effects, and uncover new drug targets has been developed by researchers at the University of Illinois at Chicago.

The finding is reported in the Proceedings of the National Academy of Sciences.

Protein kinases are enzymes involved in almost every biological process. These molecules perform a single action – they transfer phosphate from the energy molecule ATP to other enzymes and proteins. The process is a key mechanism of regulatory control and allows cells to perform all of their functions.

Several hundred different kinases work to phosphorylate various proteins and drive the entire range of cellular activities. Understanding precisely how kinases work would reveal cellular pathways that drive cells to become cancerous and identify novel drug targets.

Until now, it was difficult to study cellular processes triggered by specific kinases that turn on only briefly, says Andrei Karginov, assistant professor of pharmacology in the UIC College of Medicine.

"Previously, we had the ability to artificially turn on a kinase, but we didn't know how to turn it off," Karginov said. "So what we could see was only the result of that kinase being on for a long time."

That approach has proved useful to study the prolonged cancer-causing effects of some kinases, Karginov said.

"But, in living cells, kinases are often turned only for a set period of time, and the duration of this activation often dictates what will happen to the cell," he said.

"To mimic this transient action we had come up with a new strategy."

The new procedure allows scientists to turn kinases on, and then off – providing a powerful tool for studying the effects of kinases as they actually work in the body.

The researchers used two protein-engineering techniques to switch on and switch off one kinase, called tyrosine kinase c-Src. They were able to observe a series of structural changes when they turned the enzyme on for various periods of time.

The first wave of changes, where the cell seemed to expand and then contract, was driven by kinase activation and inactivation. Interestingly, a second expansion sometimes occurred after the kinase had been switched off – depending on how long it had been left on.

The experiment demonstrated that even short-term activation of a kinase can have a long-lasting effect on cell behavior, and allowed researchers to identify the molecular mechanism driving these events.

###

Asrar Malik, Jennifer Klomp, Vincent Huyot, Anne-Marie Ray, and Kerrie Collins of the UIC department of pharmacology are co-authors on the paper.

This research was funded by the National Institutes of Health grants R21CA159179 and T32 HL007829-22, the Chicago Biomedical Consortium and the UIC Center for Clinical and Translational Science grant UL1TR000050.

Media Contact

Sharon Parmet
[email protected]
312-413-2695
@uicnews

http://www.uic.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026

Barriers and Boosters of Seniors’ Physical Activity in Karachi

February 7, 2026

Evaluating Pediatric Emergency Care Quality in Ethiopia

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

Barriers and Boosters of Seniors’ Physical Activity in Karachi

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.